Nissui Pharmaceutical Co Ltd
TSE:4550
Nissui Pharmaceutical Co Ltd
TSE:4550
Price:
999 999.9999
JPY
Market Closed
Market Cap:
¥38.3B
Income Statement
Earnings Waterfall
Nissui Pharmaceutical Co Ltd
Nissui Pharmaceutical Co Ltd
Income Statement
Nissui Pharmaceutical Co Ltd
Nissui Pharmaceutical Co Ltd
Currency: JPY
| Mar-2022 | Jun-2022 | Sep-2022 | ||
|---|---|---|---|---|
| Revenue | ||||
| Revenue |
16 657
N/A
|
16 414
-1%
|
17 181
+5%
|
|
| Gross Profit | ||||
| Cost of Revenue |
(11 399)
|
(11 097)
|
(11 717)
|
|
| Gross Profit |
5 258
N/A
|
5 317
+1%
|
5 464
+3%
|
|
| Operating Income | ||||
| Operating Expenses |
(3 694)
|
(3 906)
|
(3 975)
|
|
| Selling, General & Administrative |
(3 003)
|
(3 906)
|
(3 974)
|
|
| Research & Development |
(691)
|
0
|
0
|
|
| Other Operating Expenses |
0
|
0
|
(1)
|
|
| Operating Income |
1 564
N/A
|
1 411
-10%
|
1 489
+6%
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
(2)
|
(26)
|
(23)
|
|
| Non-Reccuring Items |
57
|
13
|
27
|
|
| Gain/Loss on Disposition of Assets |
(1)
|
(1)
|
(2)
|
|
| Total Other Income |
31
|
25
|
(5)
|
|
| Pre-Tax Income |
1 649
N/A
|
1 422
-14%
|
1 486
+5%
|
|
| Net Income | ||||
| Tax Provision |
(503)
|
(473)
|
(475)
|
|
| Income from Continuing Operations |
1 146
|
949
|
1 011
|
|
| Net Income (Common) |
1 146
N/A
|
949
-17%
|
1 011
+7%
|
|
| EPS (Diluted) |
52.09
N/A
|
42.38
-19%
|
45.7
+8%
|
|
Switch to:
Switch to:
See Also
Discover More
